G373-2675 Screening compound: 2-{[1-(4-CHLOROBENZOYL)PIPERIDIN-4-YL]FORMAMIDO}-N-[(4-METHOXYPHENYL)METHYL]ACETAMIDE

G373-2675 Screening compound: 2-{[1-(4-CHLOROBENZOYL)PIPERIDIN-4-YL]FORMAMIDO}-N-[(4-METHOXYPHENYL)METHYL]ACETAMIDE
G373-2675 Screening compound: 2-{[1-(4-CHLOROBENZOYL)PIPERIDIN-4-YL]FORMAMIDO}-N-[(4-METHOXYPHENYL)METHYL]ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound G373-2675
2-{[1-(4-CHLOROBENZOYL)PIPERIDIN-4-YL]FORMAMIDO}-N-[(4-METHOXYPHENYL)METHYL]ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G373-2675

Molecular Formula

C23H26ClN3O4 (C23 H26 ClN3 O4)

Compound Name

2-{[1-(4-CHLOROBENZOYL)PIPERIDIN-4-YL]FORMAMIDO}-N-[(4-METHOXYPHENYL)METHYL]ACETAMIDE

IUPAC name

n/a

SMILES

COc1ccc(CNC(CNC(C(CC2)CCN2C(c(cc2)ccc2Cl)=O)=O)=O)cc1

InChI

InChI=1S/C23H26ClN3O4/c1-31-20-8-2-16(3-9-20)14-25-21(28)15-26-22(29)17-10-12-27(13-11-17)23(30)18-4-6-19(24)7-5-18/h2-9,17H,10-15H2,1H3,(H,25,28)(H,26,29)

InChI Key

TYWOEBRPATZCNG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15006285

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.93

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.445

Distribution Coefficient, logD

2.445

Water Solubility, LogSw

-3.36

Polar Surface Area

73.315

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

-1.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

G373-2675 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with G373-2675 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G373-2675?
Check Price and Availability of G373-2675, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G373-2675 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G373-2675
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G373-2675
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G373-2675 available by request